Related Experiment Video

Updated: Jun 26, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

[Progess on research of herpes simplex virus type 1 mutants for cancer therapy]

Yahong Long1, Yanxia Mi, Yunchun Li

  • 1Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi
|January 27, 2009
PubMed

Insights

Oncolytic viruses, like Herpes simplex virus type 1 (HSV-1), show promise for cancer therapy. Researchers are exploring HSV-1 mutants labeled with radionuclides for enhanced tumor treatment strategies.

Area of Science:

  • Virology
  • Oncology
  • Biotechnology

Context:

  • Viruses have long been recognized for their tumor-destroying capabilities.
  • Ongoing research focuses on developing improved oncolytic viruses for various cancers.
  • Herpes simplex virus type 1 (HSV-1) is a leading candidate among oncolytic viruses.

Purpose:

  • To provide an overview of oncolytic viruses and HSV-1 biology.
  • To discuss the construction and application of recombinant HSV-1.
  • To evaluate the potential of radionuclide-labeled HSV-1 mutants in cancer therapy.

Summary:

  • This review covers the current landscape of oncolytic viruses, detailing the biology of HSV-1.
  • It examines the engineering and utilization of recombinant HSV-1 for therapeutic purposes.
  • The feasibility and future prospects of using HSV-1 mutants tagged with radionuclides for cancer treatment are debated.

Impact:

  • Highlights the potential of HSV-1 as an oncolytic agent.
  • Discusses advancements in genetic engineering for cancer therapy.
  • Explores novel approaches combining virotherapy and radionuclide therapy for improved cancer treatment outcomes.

More Related Videos

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation12:22

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

Published on: April 2, 2012

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals08:31

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...